Clinical trials
Hepatitis B, Chronic trials with no applicable phase and unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
36 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2011 | 2 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 6 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 5 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 36 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Third Affiliated Hospital, Sun Yat-Sen University | 5 |
| Beijing Ditan Hospital | 3 |
| National Taiwan University Hospital | 3 |
| Sun Yat-sen University | 2 |
| Beijing 302 Hospital | 1 |
| California Pacific Medical Center Research Institute | 1 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 1 |
| Chulalongkorn University | 1 |
| Composite Interceptive Med Science | 1 |
| First Affiliated Hospital Xi'an Jiaotong University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hepatitis B, Chronic | 36 |
| Hepatitis B | 6 |
| Carcinoma, Hepatocellular | 2 |
| Hepatitis | 2 |
| Acute-On-Chronic Liver Failure | 1 |
| Hepatitis C, Chronic | 1 |
| Insulin Resistance | 1 |
| Lipid Metabolism Disorders | 1 |
| Liver Diseases | 1 |
| Malnutrition | 1 |
Trials
Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.